Stay updated on Dupilumab in Bullous Pemphigoid Adults Clinical Trial

Sign up to get notified when there's something new on the Dupilumab in Bullous Pemphigoid Adults Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dupilumab in Bullous Pemphigoid Adults Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added. Revision: v3.4.3 removed.
    Difference
    0.0%
    Check dated 2026-03-19T05:09:28.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Results posted on 2026-03-06 introduce a comprehensive Results section with primary and secondary efficacy outcomes (OCS exposure, BPDAI scores, pruritus NRS, ABQOL, BP involvement, and autoantibody titers) plus safety data through Week 64. Several previously reported metrics (e.g., sustained remission proportions and some BPDAI-related endpoints) were removed.
    Difference
    6%
    Check dated 2026-03-12T00:40:58.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    50 days ago
    Change Detected
    Summary
    A new site revision entry (Revision: v3.4.2) was added, and the notice about a lapse in government funding was removed; these are minor administrative updates that do not alter the study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T11:28:50.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Added a banner informing users about the lapse in government funding and NIH operating status with links to cc.nih.gov and opm.gov. Updated the site version from v3.4.0 to v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-04T10:14:29.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Show glossary feature added and two QC-related date fields introduced (Last Update Submitted that Met QC Criteria, Last Update Posted). The revision was updated to v3.4.0 and No FEAR Act data references were adjusted.
    Difference
    0.2%
    Check dated 2026-01-28T05:45:02.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    Revision: v3.3.4 appears on the page, replacing the previous Revision: v3.3.3. This seems to reflect a minor UI/version update rather than a change to study content.
    Difference
    0.0%
    Check dated 2026-01-14T02:26:18.000Z thumbnail image

Stay in the know with updates to Dupilumab in Bullous Pemphigoid Adults Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dupilumab in Bullous Pemphigoid Adults Clinical Trial page.